ZA9811316B - Novel hepatitis C virus NS5B protein - Google Patents

Novel hepatitis C virus NS5B protein

Info

Publication number
ZA9811316B
ZA9811316B ZA9811316A ZA9811316A ZA9811316B ZA 9811316 B ZA9811316 B ZA 9811316B ZA 9811316 A ZA9811316 A ZA 9811316A ZA 9811316 A ZA9811316 A ZA 9811316A ZA 9811316 B ZA9811316 B ZA 9811316B
Authority
ZA
South Africa
Prior art keywords
ns5b protein
virus ns5b
novel hepatitis
hepatitis
novel
Prior art date
Application number
ZA9811316A
Other languages
English (en)
Inventor
Alfred Del Vecchio
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA9811316B publication Critical patent/ZA9811316B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA9811316A 1997-12-11 1998-12-10 Novel hepatitis C virus NS5B protein ZA9811316B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6920897P 1997-12-11 1997-12-11

Publications (1)

Publication Number Publication Date
ZA9811316B true ZA9811316B (en) 1999-06-11

Family

ID=22087432

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811316A ZA9811316B (en) 1997-12-11 1998-12-10 Novel hepatitis C virus NS5B protein

Country Status (8)

Country Link
US (3) US6228576B1 (ja)
EP (1) EP1037974B1 (ja)
JP (1) JP2001526028A (ja)
AU (1) AU1905399A (ja)
CA (1) CA2312484A1 (ja)
DE (1) DE69838513T2 (ja)
WO (1) WO1999029843A1 (ja)
ZA (1) ZA9811316B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078500B1 (en) 1998-01-30 2006-07-18 The General Hospital Corporation Genetic immunization with nonstructural proteins of hepatitis C virus
CA2318744A1 (en) * 1998-01-30 1999-08-05 The General Hospital Corporation Genetic immunization with nonstructural proteins of hepatitis c virus
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US20040101829A1 (en) * 2002-06-28 2004-05-27 The University Of Iowa Research Foundation Protein that interacts with lipids and methods for treating hyperlipidemia
AU2003256678A1 (en) * 2002-07-19 2004-03-03 Myriad Genetics, Inc. Method and composition for treating and preventing hepatitis c infection
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
CN1984677A (zh) * 2004-05-17 2007-06-20 希龙公司 截短的丙肝病毒ns5结构域以及含有该截短结构域的融合蛋白
WO2006121468A1 (en) * 2004-11-22 2006-11-16 Genelabs Technologies, Inc. 5-nitro-nucleoside compounds for treating viral infections
WO2006093986A1 (en) * 2005-02-28 2006-09-08 Genelabs Technologies, Inc. Tricyclic-nucleoside prodrugs for treating viral infections
WO2006116557A1 (en) * 2005-04-25 2006-11-02 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections
WO2006138744A2 (en) * 2005-06-24 2006-12-28 Genelabs Technologies, Inc. Heteroaryl derivatives for treating viruses
US8076365B2 (en) 2005-08-12 2011-12-13 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
JP2009544622A (ja) * 2006-07-20 2009-12-17 スミスクライン・ビーチャム・コーポレーション 多環式ウイルス阻害剤
WO2009029729A1 (en) * 2007-08-31 2009-03-05 Genelabs Technologies, Inc. Amino tricyclic-nucleoside compounds, compositions, and methods of use
EP2166016A1 (en) 2008-09-18 2010-03-24 Centocor Ortho Biotech Products L.P. Phosphoramidate Derivatives of Nucleosides
WO2011039221A2 (en) 2009-09-29 2011-04-07 Centocor Ortho Biotech Products L.P. Phosphoramidate derivatives of nucleosides
AR082453A1 (es) 2010-04-21 2012-12-12 Novartis Ag Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
CA2806108A1 (en) 2010-07-22 2012-01-26 Novartis Ag 2,3,5-trisubstituted thiophene compounds and uses thereof
EP2658857B1 (en) 2010-12-29 2016-11-02 Inhibitex, Inc. Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU216017B (hu) 1987-11-18 1999-04-28 Chiron Corp. Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
US5980899A (en) 1992-06-10 1999-11-09 The United States Of America As Represented By The Department Of Health And Human Services Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
US5861267A (en) 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
CN1063442C (zh) 1995-05-18 2001-03-21 泽里新药工业株式会社 氨基噻唑衍生物、含有它们的药物组合物及其用途
IT1278077B1 (it) * 1995-05-25 1997-11-17 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
EP0859833B1 (en) * 1995-09-27 2006-03-01 Emory University Recombinant hepatitis c virus rna replicase
EP1009763A4 (en) 1996-06-11 2002-08-07 Merck & Co Inc SYNTHETIC GENES OF HEPATITIS C

Also Published As

Publication number Publication date
WO1999029843A1 (en) 1999-06-17
DE69838513T2 (de) 2008-07-03
DE69838513D1 (de) 2007-11-15
US20030190606A1 (en) 2003-10-09
CA2312484A1 (en) 1999-06-17
US20020081568A1 (en) 2002-06-27
EP1037974A1 (en) 2000-09-27
EP1037974B1 (en) 2007-10-03
EP1037974A4 (en) 2001-09-12
US6228576B1 (en) 2001-05-08
AU1905399A (en) 1999-06-28
JP2001526028A (ja) 2001-12-18

Similar Documents

Publication Publication Date Title
ZA9811316B (en) Novel hepatitis C virus NS5B protein
IL131688A0 (en) Functional dna clone for hepatitis c virus (hcv) and uses thereof
DE69940817D1 (en) Hepatitis c tripeptide inhibitoren
DE60014345D1 (en) Makrozyklische peptide als hepatitis c virus ns3 protease inhibitore
ZA985762B (en) Screening methods using an atpase protein from a virus of the flaviviridae family
EE200100080A (et) C-hepatiidi inhibiitorpeptiidid
AU3714499A (en) Hepatitis c virus mimotopes
EP0747482A3 (en) Recombinant hepatitis GB virus proteins their uses
IL143798A0 (en) Hepatitis c virus ns3 protease
EP1113777A4 (en) NOVEL HEPATITIS C VIRUS PEPTIDES AND USES THEREOF
IL138804A0 (en) Hepatitis c virus ns5b nucleic acids and proteins
IL116118A0 (en) Papaya ringspot virus coat protein gene
ZA984322B (en) Sucrose-binding proteins
HUP0003511A3 (en) Hepatitis b virus polypeptides
IL137458A0 (en) Genetic immunization with nonstructural proteins of hepatitis c virus
FI943929A0 (fi) Hepatiitti C-viruspeptidejä
AU7336296A (en) Human hepatitis b virus dna
GB9707221D0 (en) Hepatitis B virus mutations
GB9702990D0 (en) Virus vaccine
GB9721182D0 (en) Hepatitis C receptor protein
GB9813560D0 (en) Hepatitis C Receptor Protein
GB9722943D0 (en) Hepatitis B virus monoclonal antibodies
GB9722944D0 (en) Hepatitis B virus monoclonal antibodies
GB9614731D0 (en) Synthetic hepatitis C virus core protein gene
GB9806525D0 (en) Recombinant virus